CoChat

A Combined Pharmacodynamic Quantitative and Qualitative Model Reveals the Potent Activity of Daptomycin and Delafloxacin against Staphylococcus aureus Biofilms

Bauer, Julia, Siala, Wafi, Tulkens, Paul M., Van Bambeke, Françoise · 2013 · Antimicrobial Agents and Chemotherapy
Cited by 130

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Biofilms are associated with persistence of Staphylococcus aureus infections and therapeutic failures. Our aim was to set up a pharmacodynamic model comparing antibiotic activities against biofilms and examining in parallel their effects on viability and biofilm mass. Biofilms of S. aureus ATCC 25923 (methicillin-sensitive S. aureus [MSSA]) or ATCC 33591 (methicillin-resistant S. aureus [MRSA]) were obtained by culture in 96-well plates for 6 h/24 h. Antibiotic activities were assessed after 24/48 h of exposure to concentrations ranging from 0.5 to 512 times the MIC. Biofilm mass and bacterial viability were quantified using crystal violet and the redox indicator resazurin. Biofilms stained with Live/Dead probes were observed by using confocal microscopy. Concentration-effect curves fitted sigmoidal regressions, with a 50% reduction toward both matrix and viability obtained at sub-MIC or low multiples of MICs against young biofilms for all antibiotics tested. Against mature biofilms, maximal efficacies and potencies were reduced, with none of the antibiotics being able to completely destroy the matrix. Delafloxacin and daptomycin were the most potent, reducing viability by more than 50% at clinically achievable concentrations against both strains, as well as reducing biofilm depth, as observed in confocal microscopy. Rifampin, tigecycline, and moxifloxacin were effective against mature MRSA biofilms, while oxacillin demonstrated activity against MSSA. Fusidic acid, vancomycin, and linezolid were less potent overall. Antibiotic activity depends on biofilm maturity and bacterial strain. The pharmacodynamic model developed allows ranking of antibiotics with respect to efficacy and potency at clinically achievable concentrations and highlights the potential utility of daptomycin and delafloxacin for the treatment of biofilm-related infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.00181-13

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 56

  1. 10.4161/viru.2.5.17724 · DOI · Paper page
  2. 10.1111/j.1462-5822.2009.01323.x · DOI · Paper page
  3. 10.1371/journal.pone.0031780 · DOI
  4. 10.2174/092986708786848442 · DOI
  5. OttoM. 2008. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322:207–228.
  6. 10.1128/AAC.00350-06 · DOI · Paper page
  7. 10.1128/AAC.00455-10 · DOI
  8. 10.1111/j.1574-695X.2010.00701.x · DOI
  9. 10.1128/AAC.01642-08 · DOI
  10. 10.1016/j.ijantimicag.2007.11.012 · DOI
  11. 10.1016/j.ijantimicag.2007.06.029 · DOI
  12. 10.1590/S0037-86822012000400011 · DOI
  13. WuWS ChenCC ChuangYC SuBA ChiuYH HsuHJ KoWC TangHJ. 9 May 2012. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. J. Microbiol. Immunol. Infect. [Epub ahead of print.] doi:10.1016/j.jmii.2012.03.009. · DOI
  14. 10.1016/j.ijantimicag.2008.08.029 · DOI
  15. 10.1016/j.diagmicrobio.2010.11.018 · DOI
  16. 10.1016/j.ijantimicag.2008.11.004 · DOI
  17. 10.1016/j.mimet.2009.04.014 · DOI
  18. 10.1007/s12223-010-0012-y · DOI
  19. 10.1002/jobm.201000034 · DOI
  20. 10.1128/iai.37.1.318-326.1982 · DOI · Paper page
  21. 10.1128/AEM.02095-09 · DOI · Paper page
  22. 10.1111/j.1472-765X.2007.02298.x · DOI
  23. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing, 22nd informational supplement. CLSI document MS100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
  24. 10.1016/j.foodres.2005.05.006 · DOI
  25. 10.1111/j.1574-695X.2012.00961.x · DOI
  26. AmsdenGW. 2009. Tables of antimicrobial agent pharmacology, p 705–764. In MandellGL BennettJE DolinR (ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th ed. Elsevier, Philadelphia, PA.
  27. LawrenceL BenedictM HartJ HawkinsA LiD MedlockM HopkinsS BurakE. 2011. Pharmacokinetics (PK) and safety of single doses of delafloxacin administered intravenously in healthy human subjects, poster A2-045a. Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC). American Society for Microbiology, Washington, DC.
  28. Anonymous. 2005. Zyvox. U.S. full prescribing information. Pharmacia & Upjohn, Division of Pfizer, Inc., New York, NY.
  29. 10.1007/s002640050116 · DOI
  30. 10.1016/j.actbio.2009.08.040 · DOI
  31. 10.1093/jac/44.1.43 · DOI · Paper page
  32. 10.1128/AAC.01180-12 · DOI
  33. 10.1016/j.diagmicrobio.2012.05.034 · DOI
  34. 10.1038/ja.2012.49 · DOI
  35. 10.1016/j.mimet.2012.01.007 · doi:10.1016/j.mimet.2012.01.007
  36. 10.5301/ijao.5000061 · DOI
  37. 10.1007/978-1-59745-468-1_10 · DOI · Paper page
  38. 10.1016/j.jhin.2005.06.004 · DOI · Paper page
  39. 10.1128/JB.186.3.722-729.2004 · DOI · Paper page
  40. 10.1002/jobm.201000221 · DOI · Paper page
  41. 10.1093/jac/dkr043 · DOI
  42. 10.5301/ijao.5000027 · DOI · Paper page
  43. 10.1093/jac/dkq257 · DOI · Paper page
  44. 10.1128/AAC.50.3.841-851.2006 · DOI · Paper page
  45. 10.1128/AAC.01201-10 · doi:10.1128/aac.01201-10
  46. 10.1371/journal.ppat.1002626 · DOI · Paper page
  47. 10.1080/08927014.2011.604776 · DOI
  48. 10.1155/2012/976972 · doi:10.1155/2012/976972
  49. 10.1016/j.micpath.2009.09.011 · doi:10.1016/j.micpath.2009.09.011
  50. 10.1128/JCM.02280-06 · DOI · Paper page
  51. 10.2165/00003495-200969100-00005 · DOI
  52. 10.1016/j.ijantimicag.2010.03.015 · DOI
  53. 10.1007/s10096-011-1160-y · DOI
  54. 10.1093/cid/cir805 · DOI
  55. 10.1128/AEM.71.5.2501-2510.2005 · DOI · Paper page
  56. 10.1371/journal.pone.0025299 · doi:10.1371/journal.pone.0025299

Cited by

Metadata

Authors
Bauer, J., Siala, W., Tulkens, P. M., & Van Bambeke, F.
Affiliations
Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium
Venue
Antimicrobial Agents and Chemotherapy
Published
2013-06
Volume
57
Issue
6
Pages
2726-2737
ISSN
  • 0066-4804
  • 1098-6596
Cited by
130
References
9
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.